Nektar Therapeutics
NKTR
NKTR
287 hedge funds and large institutions have $3.24B invested in Nektar Therapeutics in 2019 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 126 increasing their positions, 86 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
45% less capital invested
Capital invested by funds: $5.91B → $3.24B (-$2.66B)
60% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 82
Holders
287
Holding in Top 10
2
Calls
$34M
Puts
$34.1M
Top Buyers
| 1 | +$206M | |
| 2 | +$64.1M | |
| 3 | +$38.7M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$28.2M |
| 5 |
Millennium Management
New York
|
+$18M |
Top Sellers
| 1 | -$101M | |
| 2 | -$38.6M | |
| 3 | -$26M | |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$25.4M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$18M |